(Q35909225)

English

Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts

scientific article published on 4 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1 reference

13 December 2019

evaluation study

1 reference

PubMed publication ID

Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

non-small-cell lung carcinoma

2 references

13 December 2019

based on heuristic

inferred from title

1 reference

13 December 2019

1 reference

13 December 2019

humanized antibody

1 reference

27 September 2019

1 reference

based on heuristic

inferred from title

1 reference

PubMed publication ID

author name string

M Reck

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

F Barlesi

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

L Crinò

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

C I Henschke

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

D Isla

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

S Stiebeler

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

D R Spigel

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

4 November 2011

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1 May 2012

4 references

3 April 2019

27 September 2019

27 November 2019

13 December 2019

Annals of Oncology

5 references

Europe PubMed Central

PMC publication ID

11 August 2017

3 April 2019

27 September 2019

27 November 2019

13 December 2019

23

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1111-1120

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

4 references

Europe PubMed Central

3 April 2019

Europe PubMed Central

27 September 2019

Europe PubMed Central

27 November 2019

Europe PubMed Central

13 December 2019

on focus list of Wikimedia project

0 references

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Treatment-related mortality with bevacizumab in cancer patients: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

BRIDGE: an open-label phase II trial evaluating the safety of bevacizumab + carboplatin/paclitaxel as first-line treatment for patients with advanced, previously untreated, squamous non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Increased risk of serious hemorrhage with bevacizumab in cancer patients: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Efficacy and safety of bevacizumab-based therapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer in the phase III BO17704 study (AVAiL).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Hypofractionated radiotherapy in non small cell lung cancer: a review of the current literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Plethora of agents, plethora of targets, plethora of side effects in metastatic renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Inter- and intraobserver consistency in assessing eligibility for bevacizumab (BVZ) in non-small-cell lung cancer (NSCLC) patients with centrally located tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Radiological management of hemoptysis: a comprehensive review of diagnostic imaging and bronchial arterial embolization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Bronchial artery embolization for the management of hemoptysis in oncology patients: utility and prognostic factors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Angiogenesis in the treatment of non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Retrospective evaluation of the clinical and radiographic risk factors associated with severe pulmonary hemorrhage in first-line advanced, unresectable non-small-cell lung cancer treated with Carboplatin and Paclitaxel plus bevacizumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Tumor cavitation: impact on objective response evaluation in trials of angiogenesis inhibitors in non-small-cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Palliative thoracic radiotherapy for lung cancer: a systematic review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Mechanisms of adverse effects of anti-VEGF therapy for cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Imaging of the patient with non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Computed tomography in staging for lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Bronchial artery embolization : experience with 54 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Managing life-threatening hemoptysis: has anything really changed?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Vascular involvement in pancreatic adenocarcinoma: reassessment by thin-section CT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Major and massive hemoptysis: reassessment of conservative management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

11 July 2018

Palliative thoracic radiotherapy in non-small cell lung cancer. An analysis of 1250 patients. Palliation of symptoms, tolerance and toxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

24 September 2018

Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

24 September 2018

A prospective evaluation of hemoptysis cases in a tertiary referral hospital.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

24 September 2018

Use of multidetector row CT to evaluate the need for bronchial arterial embolization in hemoptysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

24 September 2018

Multidisciplinary management of life-threatening massive hemoptysis: a 10-year experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

24 September 2018

Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

24 September 2018

Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

24 September 2018

Bronchoscopy-guided topical hemostatic tamponade therapy for the management of life-threatening hemoptysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

24 September 2018

Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335247

24 September 2018

Accuracy of computed tomographic scan and surgical assessment for staging of bronchial carcinoma. A prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bronchial artery embolization for hemoptysis: immediate and long-term results

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A reappraisal of the causes of hemoptysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Presenting conditions of 1539 population-based lung cancer patients by cell type and stage in New Hampshire and Vermont

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical manifestations of lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemorrhage from carcinoma of the lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mediastinal invasion by bronchogenic carcinoma: CT signs

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endobronchial argon plasma coagulation for treatment of hemoptysis and neoplastic airway obstruction

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemoptysis: diagnosis and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical Lung Resection for Severe Hemoptysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22056855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/ANNONC/MDR463

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35909225&oldid=1616308981"